# A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn’s disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-systematic-review-and-economic-evaluation-of-the-use-of-tumour-necrosis-factor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Janine Dretzke,Richard Edlin,Jeff Round,Martin Connock,Claire Hulme,J Czeczot,A Fry-Smith,Christopher McCabe,Catherine Meads |
| Citations | 132 |
| DOI | 10.3310/hta15060 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://njl-admin.nihr.ac.uk/document/download/2002093 |
| OpenAlex ID | https://openalex.org/W2133115874 |
| PMID | 21291629 |
| Type | review |
| Year | 2011 |

## Paper authors

- [Jeff Round](https://scholariq.org/researchers/jeff-round/)

## Paper journal

- [Health Technology Assessment](https://scholariq.org/journals/health-technology-assessment/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.